CliffBio
small molecule

BONTRIL

PHENDIMETRAZINE TARTRATE

Loss of exclusivity—loss of exclusivity
CompanyVALEANT PHARMACEUTICALS INTERNATIONAL

Drug detail

Brand nameBONTRIL
Active ingredientPHENDIMETRAZINE TARTRATE
Strength105MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 1982
Marketing statusDISCN

More from VALEANT PHARMACEUTICALS INTERNATIONAL

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BONTRIL patent cliff — loss of exclusivity — | CliffBio